by CheckRare Staff | Sep 19, 2023
Shoshana Shendelman, PhD, President and Chief Executive Officer of Applied Therapeutics, explains the urgency of finding newer treatment options for galactosemia patients. Galactosemia is a rare, metabolic disorder that affects an individual’s...
by CheckRare Staff | Sep 18, 2023
Mary McGowan, MD, chief medical officer of the Family Heart Foundation explains when it is recommended that children be screened with a lipid profile. T The American Academy of Pediatrics and the National Heart, Lung, and Blood Institute of the NIH...
by CheckRare Staff | Sep 14, 2023
Ben Munoz, co-founder of Ben’s Friends, talks about his non-profit organization. Ben’s Friends is a 501(c)(3) non-profit designed to provide a network for patients with rare diseases or chronic illnesses. Its goal is to be a safe and supportive place for...
by CheckRare Staff | Sep 6, 2023
Shoshana Shendelman, PhD, President and Chief Executive Officer of Applied Therapeutics, discusses the results of the Phase 3 clinical trial testing govorestat to treat galactosemia. Galactosemia is a rare, metabolic disorder that affects a person’s...
by CheckRare Staff | Sep 5, 2023
Mona Al Mukaddam, MD, Associate Professor of Clinical Medicine and Orthopaedic Surgery at Penn Medicine, describes fibrodysplasia ossificans progressiva (FOP). FOP is genetic disorder characterized by new bone formation outside of the normal skeletal...
